The process for placing food products with CBD on the market has been subject to much debate, especially so following the change in the EU’s Novel Food Catalogue where all cannabinoid-containing extracts are now seen as novel and therefore require a pre-market authorisation. This report provides invaluable information about Article 4 – which could potentially avoid the burdensome implications of submitting a novel food application under Article 10, instead allowing consultation with a member state over whether a food is considered novel.
1 Introduction 2 What’s the industry’s position? 3 What does the Article 4 process entail? 4 Will I be allowed to place a product on the market throughout the EU if my foodstuff is approved under Article 4? 5 What are the steps towards a consultation of novel food status? 6 What are the (potential) advantages?
Need help?
Contact a sales representative right now and don’t wait
“ Regulatory report: the path to the market for CBD foods under Article 4 ”
Buy report request information:
“ Regulatory report: the path to the market for CBD foods under Article 4 ”
We also invite you to enjoy our FREE TRIAL
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.